Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands-A nationwide study

Introduction: Serous ovarian carcinomas constitute the largest group of epithelial ovarian cancer (60%–75%) and are further classified into high- and low-grade serous carcinoma. Low-grade serous carcinoma (LGSC) is a relatively rare subtype (approximately 5% of serous carcinomas) and epidemiologic studies of large cohorts are scarce. With the present study we aimed to report trends in stage, primary treatment and relative survival of LGSC of the ovary in a large cohort of patients in an effort to identify opportunities to improve clinical practice and outcome of this relatively rare disease. M... Mehr ...

Verfasser: De Decker, K.
Wenzel, H.H.B.
Bart, J.
van der Aa, M.
Kruitwagen, R.F.P.M.
Nijman, H.W.
Kruse, A.J.
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: De Decker , K , Wenzel , H H B , Bart , J , van der Aa , M , Kruitwagen , R F P M , Nijman , H W & Kruse , A J 2023 , ' Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands-A nationwide study ' , Acta Obstetricia et Gynecologica Scandinavica , vol. 102 , no. 3 , pp. 246-256 . https://doi.org/10.1111/aogs.14518
Schlagwörter: cytoreductive surgery / debulking surgical procedure / epithelial / ovarian cancer / ovarian epithelial carcinoma / ovarian neoplasms / CANCER / CYTOREDUCTION / PATHOLOGY / TUMOR / WOMEN
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26821627
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/77e73d92-9d0c-4da9-9a19-521c4cd1b0ae